tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Optimistic Buy Rating for Fortress Biotech Driven by Promising CUTX-101 Prospects and FDA Engagement
PremiumRatingsOptimistic Buy Rating for Fortress Biotech Driven by Promising CUTX-101 Prospects and FDA Engagement
2M ago
Fortress Biotech’s CUTX-101 NDA Resubmission Accepted by FDA
Premium
Company Announcements
Fortress Biotech’s CUTX-101 NDA Resubmission Accepted by FDA
2M ago
Fortress Biotech, Cyprium announce FDA acceptance of CUTX-101 NDA resubmission
Premium
The Fly
Fortress Biotech, Cyprium announce FDA acceptance of CUTX-101 NDA resubmission
2M ago
Fortress Biotech reports Q3 EPS 11c vs (76c) last year
PremiumThe FlyFortress Biotech reports Q3 EPS 11c vs (76c) last year
3M ago
Fortress subsidiary announces Crystalys dosed patient in study of dotinurad
Premium
The Fly
Fortress subsidiary announces Crystalys dosed patient in study of dotinurad
4M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
4M ago
Fortress Biotech, Urica announces Crystalys’ $205M Series A financing
PremiumThe FlyFortress Biotech, Urica announces Crystalys’ $205M Series A financing
4M ago
Fortress Biotech, Cyprium receive CRL related to NDA for CUTX-101
Premium
The Fly
Fortress Biotech, Cyprium receive CRL related to NDA for CUTX-101
4M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100